GTR Home > Tests > Search results - 610219[mim]

Apply filters

Showing tests for all 1710 conditions

Compare labs

Your search term can be found in tests with a total of 1710 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 610219[mim]

C Clinical test, R Research test

Showing 1 to 20 of 24 tests for 1710 conditions in 15 labs

COtoGenome Test for Hearing Loss (87 Genes)

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (112)
Total targets (86)

CDeafness, autosomal recessive type 59

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CDeafness, non-syndromic sensorineural AR panel

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (44)
Total targets (43)

CDeafness, Autosomal Recessive 59 (DFNB59) via the DFNB59 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CNonsyndromic Hearing Loss and Deafness NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (52)
Total targets (49)

COtoSCOPE

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (98)
Total targets (92)

CHearing Loss Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (121)

CNon syndromic deafness AD, AR and XL (NGS panel for 79 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Total conditions (74)
Total targets (79)

CNon syndromic deafness AR and XL (NGS panel for 56 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (52)
Total targets (56)

CDeafness, autosomal recessive 59 (sequence analysis of DFNB59 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CDFNB59 Nonsyndromic deafness

Test targets
Methods
  • C Sequence analysis of the entire coding region

CHearing Loss, nonsyndromic, autosomal recessive and X-linked Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (53)

CDFNB59

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSensorineural Hearing Loss

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (81)
Total targets (78)

Showing 1 to 20 of 24 tests for 1710 conditions in 15 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.